Artemether and Praziquantel a green light to treat the resistance schistosomiasis: A case Report

Schistosomiasis is a neglected tropical disease (NTD) that remains one of the most prevalent parasitic infections in Africa , S. mansoni and S. haematobium are the most common species that infect humans and the Praziquantel (PZQ) is the drug of choice for treatment despite the recent resistance to it .In this case report, we present an augmenting evidence to support the use of combination regimen of antimalarial drug, Artemether (ART) along with Praziquantel, as an efficient methodology in the treatment of resistant urinary schistosomiasis.